检索
AI 对话
AI 辅写
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Oral Abstract: TCL-150: The ECHELON-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma

Swaminathan Iyer,Lorenz Trümper, Owen A. O’Connor,Barbara Pro,Tim Illidge,Ranjana Advani,Nancy L. Bartlett,Jacob Haaber Christensen, Franck Morschhauser,Eva Domingo-Domenech,Giuseppe Rossi, Won Seog Kim,Tatyana Feldman,Tobias Menne,David Belada,Árpád Illès,Kensei Tobinai,Kunihiro Tsukasaki,Su-Peng Yeh,Andrei Shustov

Clinical Lymphoma Myeloma and Leukemia（2021）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要